trial

Continued Early Intervention for Recent-onset Schizophrenia

NCTId NCT00184509
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Terminated
Enrollment 50
Sponsored by Norwegian University of Science and Technology
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Terminated
Enrollment
50
Study type
Interventional
Allocation
Randomized
Model
Single Group
Masking
None
Start
1993-02
Primary completion
—
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
integrated psychosocial treatment (behavior)

Sponsors

Norwegian University of Science and TechnologyLead Sponsor
The Research Council of NorwayCollaborator

Investigators

1
K. Gunnar Gøtestam, MDStudy Director

Sites

1 total
Trondheim, Norway

Facts & assertions

3 sourced
Enrollment
50
Phase
PHASE3
Status
TERMINATED
relationships
The graph out of here
drug
integrated psychosocial treatment (behavior)
drug
lead_sponsor
Norwegian University of Science and Technology
company
collaborator
The Research Council of Norway
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
K. Gunnar Gøtestam, MD
person